Progressive multifocal leukoencephalopathy in chronic lymphocytic leukemia: A report of three cases and review of the literature

Clinical Lymphoma, Myeloma and Leukemia

Volumn 10, Issue 1, 2010, Pages E1-

  D'Souza, Anita ^a   Wilson, Jon ^a   Mukherjee, Sudipto ^a   Jaiyesimi, Ishmael ^a  

^a WILLIAM BEAUMONT HOSPITAL   (United States)

Author keywords

Alemtuzumab; Fludarabine; JC virus; Rituximab

Indexed keywords

ALEMTUZUMAB; CHLORAMBUCIL; CYCLOPHOSPHAMIDE; FLUDARABINE; PENTOSTATIN; RITUXIMAB; MONOCLONAL ANTIBODY;

ADULT; AGED; BRAIN BIOPSY; CANCER CHEMOTHERAPY; CASE REPORT; CEREBROSPINAL FLUID ANALYSIS; CERVICAL LYMPHADENOPATHY; CHRONIC LYMPHATIC LEUKEMIA; DRUG WITHDRAWAL; HUMAN; JC VIRUS; LEUKOPENIA; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PALLIATIVE THERAPY; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; REVIEW; SPLENOMEGALY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; MIDDLE AGED; PATHOLOGY;

AGED; ANTIBODIES, MONOCLONAL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; LEUKOENCEPHALOPATHY, PROGRESSIVE MULTIFOCAL; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED;

EID: 77954061826     PISSN: 21522650     EISSN: 21522669     Source Type: Journal    
DOI: 10.3816/CLML.2010.n.009     Document Type: Review

References (65)

1. Berger JR. Progressive Multifocal Leukoencephalopathy. Curr Treat Options Neurol 2000; 2:361-8.
2. San-Andres FJ, Rubio R, Castilla J, et al. Incidence of acquired immunodeficiency syndrome-associated opportunistic diseases and the effect of treatment on a cohort of 1115 patients infected with human immunodeficiency virus, 1989-1997. Clin Infect Dis 2003; 36:1177-85. (Pubitemid 36549641)
3. Weber T. Progressive Multifocal Leukoencephalopathy. Neurol Clin 2008; 26:833-54 x-xi. (Pubitemid 352020489)
4. Kimura A, Ueyama H, Kimura N, et al. Progressive Multifocal Leukoencephalopathy in an HTLV-1 carrier. Clin Neurol Neurosurg 2006; 108:768-71. (Pubitemid 44709775)
5. Angelini L, Pietrogrande M, Delle Piane M, et al. Progressive Multifocal Leukoencephalopathy in a child with hyperimmunoglobulin E recurrent infection syndrome and review of literature. Neuropediatrics 2001; 32:250-5. (Pubitemid 33134250)
6. Aschermann Z, Gomori E, Kovacs G, et al. X-linked hyper-IgM syndrome associated with a rapid course of multifocal leukoencephalopathy. Arch Neurol 2007; 64:273-6.
7. Colucci M, Cocito L, Capello E, et al. Progressive Multifocal Leukoencephalopathy in an adult patient with ICF syndrome. J Neurol Sci 2004; 217:107-10. (Pubitemid 37532723)
8. Parvaneh N, Ashrafi M, Yeganeh M, et al. Progressive multifocal leukoencephalopathy in purine nucleoside phosphorylase deficiency. Brain Dev 2007; 29:124-6. (Pubitemid 46162043)
9. Astrom K, Macall E, Richardson EP, Jr. Progressive Multifocal Leukoencephalopathy. Brain 1958; 81:93-127.
10. Garcia-Suarez J, Miguel D, Krsnik I, et al. Changes in the Natural History of Progressive Multifocal Leukoencephalopathy in HIV-Negative Lymphoproliferative Disorders: Impact of Novel Therapies. Am J Hematol 2005; 80:271-81. (Pubitemid 41746174)
11. U.S. Food and Drug Administration [Web site]. Drug Safety Communications. 2009;2(2). Available at: http://www.fda.gov/Drugs/DrugSafety/ DrugSafetyNewsletter/ ucm167884.htm. Accessed: December 30, 2009.
12. Kitamura T, Aso Y, Kuniyoshi N, et al. High incidence of urinary JC virus excretion in nonimmunosuppressed older patients. J Infect Dis 1990; 161:1128-33. (Pubitemid 20177872)
13. Eash S, Tavares R, Stopa EG, et al. Diffreential Distribution of the JC Virus Receptor-Type sialic Acid in Normal Human Tissues. Am J Pathol 2004; 164:419-28. (Pubitemid 38364658)
14. Gallia G, Houff S, Major E, et al. Review: JC virus infection of lymphocytes-revisited. J Infect Dis 1997; 176:1603-9. (Pubitemid 27518163)
15. Houff S, Major E, Katz D, et al. Involvement of JC virus-infected mononuclear cells from the bone marrow and spleen in the pathogenesis of progressive multifocal leukoencephalopathy. N Engl J Med 1988; 318:301-5. (Pubitemid 18034522)
16. Atwood W, Amemiya K, Traub R, et al. Interaction of the human polyomavirus, JCV, with human B-lymphocytes. Virology 1992; 190:716-23.
17. Tornatore C, Berger J, Houff S, et al. Detection of JC virus DNA in peripheral lymphocytes from patients with and without progressive multifocal leukoencephalopathy. Ann Neurol 1992; 31:454-62.
18. Ault G. Activity of JC virus archetype and PML-type regulatory regions in glial cells. J Gen Virol 1997; 78:163-9. (Pubitemid 27067527)
19. Seth P, Diaz F, Major EO. Advances in the biology of JC virus and induction of progressive multifocal leukoencephalopathy. J Neurovirol 2003; 9:236-45.
20. Du Pasquier RA, Corey S, Margolin DH, et al. Productive infection of cerebellar granule cell neurons by JC virus in an HIV+ individual. Neurology 2003; 61:775-82. (Pubitemid 37174472)
21. Tyler KL. The univited guest: JC virus infection in neurons in PML. Neurology 2003; 61:734-5. (Pubitemid 37174467)
22. Wuthrich C, Cheng YM, Joseph JT, et al. Frequent Infection of Cerebellar Granule Cell Neurons by Polyomavirus JC in Progressive Multifocal Leukoencephalopathy. J Neuropathol Exp Neurol 2009; 68:15-25.
23. Koralnik IJ. New insights into progressive multifocal leukoencephalopathy. Curr Opin Neurol 2004; 17:365-70. (Pubitemid 38720991)
24. Koralnik IJ, Du Pasquier RA, Letvin NL. JC virus-specific cytotoxic T lymphocytes in individuals with progressive multifocal leukoencephalopathy. J Virol 2001; 75:3483-7. (Pubitemid 32225913)
25. Hensel M, Kornacker M, Yammeni S, et al. Disease activity and pretreatment, rather than hypogammaglobulinemia, are major risk factors for infectious complications in patients with chronic lymphocytic leukemia. Br J Haematol 2003; 122:600-6. (Pubitemid 36995214)
26. Gorgun G, Holderried T, Zahrieh D, et al. Chronic lymphocytic leukemia cells induce changes in gene expression of CD4 and CD8 T cells. J Clin Invest 2005; 115:1797-805. (Pubitemid 40979718)
27. O'Shaughnessy D, Goldman JM, Roddie M, et al. Dizziness and confusion after bone marrow transplantation. BMJ 1994; 309:262-5.
28. Coppo P, Laporte JP, Aoudjhane M, et al. Progressive multifocal leucoencephalopathy with peripheral demyelinating neuropathy after autologous bone marrow transplantation for acute myeloblastic leukemia (FAB5). Bone Marrow Transplant 1999; 23:401-3. (Pubitemid 29105966)
29. Uppenkamp M, Engert A, Diehl V, et al. Monoclonal antibody therapy with CAMPATH-1H in patients with relapsed high- and low-grade non-Hodgkin's lymphomas: a multicenter phase I/II study. Ann Hematol 2002; 8:26-32. (Pubitemid 36075492)
30. Buckanovich R, Liu G, Stricker C, et al. Nonmyeloablative allogeneic stem cell transplantation for refractory Hodgkin lymphoma complicated by interleukin-2 responsive progressive multifocal leukoencephalopathy. Ann Hematol 2002; 81:410-3. (Pubitemid 36067653)
31. Martin SI, Marty FM, Fiumara K, et al. Infectious complications associated with alemtuzumab use for lymphoproliferative disorders. Clin Infect Dis 2006; 43:16-24. (Pubitemid 43939071)
32. Kharfan-Dabaja M, Ayala E, Greene J, et al. Two cases of progressive multifocal leukoencephalopathy after allogeneic hematopoietic cell transplantation and a review of the literature. Bone Marrow Transplant 2007; 39:101-7. (Pubitemid 46085228)
33. Focosi D, Fazzi R, Montanaro D, et al. Progressive multifocal leukoencephalopathy in a haploidentical stem cell transplant recipient: a clinical, neuroradiological and virological response after treatment with risperidone. Antiviral Res 2007; 74:156-8. (Pubitemid 46436167)
34. Chowdhary S, Chalmers L, Chamberlain M. Non-HIV-Related Progressive Multifocal Leukoencephalopathy (PML): A Tertiary Cancer Center Experience. J Neuroimaging 2007; 17:69-73. (Pubitemid 46066608)
35. Bonavita S, Conforti R, Russo A, et al. Infratentorial progressive multifocal leukoencephalopathy in a patient treated with fludarabine and rituximab. Neurol Sci 2008; 29:37-9.
36. Carson KR, Evens AM, Richey EA, et al. Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports Project. Blood 2009; 113:4834-40.
37. Bower JH, Hammack J, McDonnell S, et al. The neurologic complications of B-cell chronic lymphocytic leukemia. Neurology 1997; 48:407-12. (Pubitemid 27087612)
38. Gonzalez H, Bolgert F, Camporo P, et al. Progressive Multifocal Leukoencephalitis (PML) in three patients treated with standard dose fludarabine (FAMP). Hematol Cell Ther 1999; 41:183-6. (Pubitemid 29470750)
39. Wijermans PW, Gerrits WB, Haak HL. Severe immunodeficiency in patients treated with fludarabine monophosphate. Eur J Haematol 1993; 50:292-6. (Pubitemid 23224512)
40. Cheson BD. Infectious and Immunosuppressive complications of purine analog therapy. J Clin Oncol 1995; 13:2431-48.
41. Lazzarino M, Orlandi E, Baldanti F, et al. The immunosuppression and potential for EBV reactivation of fludarabine combined with cyclophosphamide and dexamethasone in patients with lymphoproliferative disorders. Br J Haematol 1999; 107:877-82. (Pubitemid 30020163)
42. Freim Wahl S, Folvik M, Torp S. Progressive multifocal leukoencephalopathy in a lymphoma patient with complete remission after treatment with cytostatics and rituximab: case report and review of literature. Clin Neuropathol 2007; 26:68-73. (Pubitemid 46408582)
43. Rey J, Belmecheri N, Bouayed N, et al. JC papovavirus leukoencephalopathy after first line treatment with CHOP and rituximab. Haematologica 2007; 92:e101.
44. Brito-Babapulle F, Moule S, Stewart W, et al. Progressive multifocal leukoencephalopathy (PML) following Rituximab-combination chemotherapy treatement. Br J Haematol 2006; 133(S1):36.
45. Peleg AY, Husain S, Kwak EJ, et al. Opportunistic infections in 547 organ transplant recipients receiving alemtuzumab, a humanized monoclonal anti-CD52 antibody. Clin Infect Dis 2007; 44:204-12. (Pubitemid 46079982)
46. Waggoner J, Martinu T, Palmer SM. Progressive multifocal leukoencephalopathy following heightened immunosuppression after lung transplant. J Heart Lung Transplant 2009; 28:395-8.
47. Mesquita R, Parravicini C, Bjorkholm M, et al. Macrophage association of polyomavirus in progressive multifocal leukoencephalopathy: an immunohistochemical and ultrastructural study. Case report. APMIS 1992; 100:993-1000. (Pubitemid 23012563)
48. Seong D, Bruner JM, Lee KH, et al. Progressive multifocal leukoencephalopathy after autologous bone marrow transplantation in a patient with chronic myelogenous leukemia. Clin Infect Dis 1996; 23:402-3. (Pubitemid 26264934)
49. Przepiorka D, Jaeckle KA, Birdwell RR, et al. Successful treatment of progressive multifocal leukoencephalopathy with low-dose interleukin-2. Bone Marrow Transplant 1997; 20:983-7. (Pubitemid 27510963)
50. Re D, Bamborschke S, Feiden W, et al. Progressive multifocal leukoencephalopathy after autologous bone marrow transplantation and alpha-interferon immunotherapy. Bone Marrow Transplant 1999; 23:295-8. (Pubitemid 29078345)
51. Osorio S, de la Camara R, Golbano N, et al. Progressive multifocal leukoencephalopathy after stem cell transplantation, unsuccessfully treated with cidofovir. Bone Marrow Transplant 2002; 30:963-6. (Pubitemid 36097487)
52. Goldberg SL, Pecora AL, Alter RS, et al. Unusual viral infections (progressive multifocal leukoencephalopathy and cytomegalovirus disease) after high-dose chemotherapy with autologous blood stem cell rescue and peritransplantation rituximab. Blood 2002; 99:1486-8. (Pubitemid 34547110)
53. Steurer M, Clausen J, Gotwald T, et al. Progressive multifocal leukoencephalopathy after allogeneic stem cell transplantation and posttransplantation rituximab. Transplantation 2003; 76:435-6. (Pubitemid 36928014)
54. Owen RG, Patmore RD, Smith GM, et al. Cytomegalovirus-induced T-cell proliferation and the development of progressive multifocal leucoencephalopathy following bone marrow transplantation. Br J Haematol 1995; 89:196-8.
55. Pelosini M, Focosi D, Rita F, et al. Progressive multifocal leukoencephalopathy: report of three cases in HIV-negative hematological patients and review of literature. Ann Hematol 2008; 87:405-12.
56. Nachbaur D, Kropshofer G, Heitger A, et al. Phenotypic and functional lymphocyte recovery after CD34-enriched versus non-T cell-depleted autologous peripheral blood stem cell transplantation. J Hematother Stem Cell Res 2000; 9:727-36.
57. Koralnik IJ, Boden D, Mai X, et al. JC Virus DNA load in patients with and without progressive multifocal leukoencephalopathy. Neurology 1999; 52:253-60. (Pubitemid 29059048)
58. Koralnik IJ. Progressive multifocal leukoencephalopathy revisited; Has the disease outgrown its name? Ann Neurol 2006; 60:162-73. (Pubitemid 44182391)
59. Hall C, Dafni U, Simpson D, et al. Failure of cytarabine in progressive multifocal leukoencephalopathy associated with human immunodeficiency virus infection. N Engl J Med 1998; 338:1345-51. (Pubitemid 28216663)
60. Marra CM, Rajijic N, Barker D, et al. A pilot study of cidofovir for progressive mulitfocal leukoencephalopathy in AIDS. AIDS 2002; 16:1791-7.
61. Geschwind M, Skolasky R, Royal W, et al. The relative complications of HAART and alpha-interferon for therapy of progressive mulitfocal leukoencephalopathy in AIDS. J Neurovirol 2001; 7:353-7. (Pubitemid 32894241)
62. Stuve O, Marra CM, Cravens PD, et al. Potential risk of Progressive Multifocal Leukoencephalopathy with Natalizumab therapy: possible interventions. Arch Neurol 2007; 64:169-76.
63. Elphick G, Querbes W, Jordan J, et al. The human polyoma virus, JCV, uses serotonin recpetors to infect cells. Science 2004; 306:1380-3. (Pubitemid 39532516)
64. Focosi D, Kast R, Maggi F, et al. Risperidone-induced reduction in JC viruria as a surrogate marker for efficacy against progressive multifocal leukoencephalopathy and hemorrhagic cystitis. J Clin Virol 2007; 39:63-4. (Pubitemid 46575345)
65. Verma S, Cikurel K, Koralnik IJ, et al. Mirtazapine in Progressive Multifocal Leukoencephalopathy Associated with Polycythemia vera. J Infect Dis 2007; 196:709-11. (Pubitemid 47293853)